However, the ability to kill leukemia cells can significantly increase when CAR-MSCs are generated through costimulation with the 4-1BB ligand, not 4-1BB, which is usually used in CAR-T cells because 4-1BBL can crosslink with the 4-1BB molecule on activated T cells [134]. Here, TNFRSF9 is linked to leukemia.